Key facts
- Blinkcns’s last known valuation is $50.2M (May 2025).
- It has raised $17.5M; the latest was Later Stage VC ($6.2M) in May 2025.
- Notable investors include Fox Ventures, Medical University of South Carolina, NeuroTechnology Investors.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Blinkcns
- ·The full record, as it builds
Funding rounds
No funding rounds for Blinkcns are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blinkcns
Developer of a blink reflex assessment technology designed to improve the detection, differentiation and management of neurological diseases. The company's technology delivers objective data about the blink reflex within minutes by stimulating and measuring the blink using light puffs of air videography, enabling doctors and trainers to identify if a patient has a concussion, to keep athletes safer through a rapid, noninvasive diagnosis of their eyes.
- Sector
- Healthcare
- HQ
- Charleston, SC, United States
- Founded
- 2017
- Employees
- 8
- Website
- blinkcns.com/
- Ownership
- Privately Held (backing)
Blinkcns doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blinkcns shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blinkcns in its N-PORT filings yet. We sweep new filings monthly.